SyncThink's EYE-SYNC receives CE mark

SyncThink, a neurotechnology company, and makers of the EYE-SYNC technology, has completed CE Mark certification, affirming conformity to European Medical Device Regulation (MDR). EYE-SYNC will be registered as a Class I medical device.

Their CEO Gary Gregory said: “The CE mark authorisation for EYE-SYNC is a tremendous advancement in our commitment to bringing objective, reliable measures of neurological function to healthcare providers in Europe. We are excited to expand our commercial opportunities and strengthen our position in the market, while making our product more accessible to patients everywhere.”